Identification and functional analysis of CBLB mutations in type 1 diabetes

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Casitas B-lineage lymphoma b (Cblb) acts as a negative regulator of T-cell activation.
• Cblb dysfunction is linked to autoimmunity in animal models.
• A Cblb nonsense mutation is implicated in a rat model of autoimmune type 1 diabetes.

Purpose of the Study:

• To investigate the potential role of CBLB mutations in human type 1 diabetes.
• To screen for CBLB mutations in Japanese subjects with type 1 diabetes.
• To functionally characterize identified CBLB mutations.

Main Methods:

• Mutation screening of the CBLB gene in Japanese type 1 diabetes patients.
• Functional characterization of identified missense mutations, including T-cell activation assays.
• Analysis of structure-function relationships of CBLB protein.

Main Results:

• Six missense mutations (A155V, F328L, N466D, K837R, T882A, R968L) were identified in Japanese subjects.
• The F328L mutation demonstrated impaired suppression of T-cell activation, indicating a loss-of-function.
• The N466D mutation was found in multiple subjects.

Conclusions:

• The F328L CBLB mutation is implicated in the development of autoimmune diseases, including type 1 diabetes.
• These findings provide insights into the structure-function relationship of the CBLB protein.
• CBLB mutations represent a potential factor in the pathogenesis of type 1 diabetes.